Navidea Biopharmaceuticals to Present at the 2014 LD Micro Conference
November 25 2014 - 7:30AM
Business Wire
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a
biopharmaceutical company focused on precision diagnostic
radiopharmaceuticals, today announced that Rick Gonzalez, Chief
Executive Officer, will participate at the annual LD Micro
Conference, being held December 2-4, 2014 in Los Angeles, CA. Mr.
Gonzalez will present a Company update on Thursday, December 4,
2014 at 8:30 AM PT.
Investors and the public are invited to view the live webcast of
Mr Gonzalez’s presentation at
http://wsw.com/webcast/ldmicro7/navb. Following the
conference, the webcast will be archived for approximately 30
days.
Attending investors who would like to schedule a meeting with
Navidea during the conference may do so by contacting Navidea
directly or using the 1-on-1 meeting request on the LD Micro
conference website.
About Navidea Biopharmaceuticals Inc.Navidea
Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a biopharmaceutical
company focused on the development and commercialization of
precision diagnostics and radiopharmaceutical agents. Navidea is
developing multiple precision diagnostic products and platforms
including Manocept™, NAV4694, NAV5001, and NAV1800 (RIGScan™), to
help identify the sites and pathways of undetected disease and
enable better diagnostic accuracy, clinical decision-making and,
ultimately, patient care. Lymphoseek® (technetium Tc 99m
tilmanocept) injection, Navidea’s first commercial product from the
Manocept platform, was approved by the FDA in March 2013 and by the
EMA in November 2014. Navidea’s strategy is to deliver superior
growth and shareholder return by bringing to market novel
radiopharmaceutical agents and therapies advancing the Company’s
pipeline through selective acquisitions, global partnering and
commercialization efforts. For more information, please visit
www.navidea.com.
Navidea BiopharmaceuticalsBrent Larson, 614-822-2330Executive VP
& CFOorSharon Correia, 978-655-2686Associate Director,
Corporate Communications
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From Sep 2023 to Sep 2024